» Articles » PMID: 11090623

A Mechanism for Modulation of Cellular Responses to VEGF: Activation of the Integrins

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2000 Nov 25
PMID 11090623
Citations 176
Authors
Affiliations
Soon will be listed here.
Abstract

Many similarities exist in the cellular responses elicited by VEGF and governed by integrins. Here, we identify a basis for these interrelationships: VEGF activates integrins. VEGF enhanced cell adhesion, migration, soluble ligand binding, and adenovirus gene transfer mediated by alphavbeta3 and also activated other integrins, alphavbeta5, alpha5beta1, and alpha2beta1, involved in angiogenesis. Certain tumor cells exhibited high spontaneous adhesion and migration, which were attributable to a VEGF-dependent autocrine/paracrine activation of integrins. This activation was mediated by the VEGFR2 receptor and regulated via phosphatidylinositol-3-kinase, Akt, and the PTEN signaling axis. Thus, integrin activation provides a mechanism for VEGF to induce a broad spectrum of cellular responses.

Citing Articles

Luminescent sensing of conformational integrin activation in living cells.

Villari G, Gioelli N, Gino M, Zhang H, Hodge K, Cordero F Cell Rep. 2025; 44(2):115319.

PMID: 39964812 PMC: 11861568. DOI: 10.1016/j.celrep.2025.115319.


Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment.

Zhang H, Li S, Wang D, Liu S, Xiao T, Gu W Biomark Res. 2024; 12(1):96.

PMID: 39227970 PMC: 11373140. DOI: 10.1186/s40364-024-00646-1.


The role of extracellular matrix in angiogenesis: Beyond adhesion and structure.

Libby J, Royce H, Walker S, Li L Biomater Biosyst. 2024; 15:100097.

PMID: 39129826 PMC: 11315062. DOI: 10.1016/j.bbiosy.2024.100097.


ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interaction.

Benedetti A, Turco C, Gallo E, Daralioti T, Sacconi A, Pulito C Cell Death Dis. 2024; 15(2):113.

PMID: 38321003 PMC: 10847507. DOI: 10.1038/s41419-024-06491-2.


Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide.

Flies C, Friedrich M, Lohmann P, van Garderen K, Smits M, Tonn J Neuro Oncol. 2024; 26(5):902-910.

PMID: 38219019 PMC: 11066942. DOI: 10.1093/neuonc/noad247.